Ono Pharmaceutical Valuation
| OPHLF Stock | USD 11.50 0.90 8.49% |
At this time, the company appears to be overvalued. Ono Pharmaceutical holds a recent Real Value of $9.91 per share. The prevailing price of the company is $11.5. Our model determines the value of Ono Pharmaceutical from analyzing the company fundamentals such as Shares Outstanding of 488.31 M, operating margin of 0.35 %, and Return On Equity of 0.16 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Ono Pharmaceutical's price fluctuation is moderately volatile at this time. Calculation of the real value of Ono Pharmaceutical is based on 3 months time horizon. Increasing Ono Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Ono pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Ono Pharmaceutical Co. Since Ono Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ono Pink Sheet. However, Ono Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.5 | Real 9.91 | Hype 11.5 |
The real value of Ono Pink Sheet, also known as its intrinsic value, is the underlying worth of Ono Pharmaceutical Company, which is reflected in its stock price. It is based on Ono Pharmaceutical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ono Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ono Pharmaceutical Co helps investors to forecast how Ono pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ono Pharmaceutical more accurately as focusing exclusively on Ono Pharmaceutical's fundamentals will not take into account other important factors: Ono Pharmaceutical Total Value Analysis
Ono Pharmaceutical Co is now expected to have takeover price of 11.13 B with market capitalization of 10.62 B, debt of 8.65 B, and cash on hands of 136.18 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ono Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.13 B | 10.62 B | 8.65 B | 136.18 B |
Ono Pharmaceutical Investor Information
About 16.0% of the company outstanding shares are owned by corporate insiders. The book value of Ono Pharmaceutical was now reported as 1477.28. The company last dividend was issued on the 30th of March 2023. Ono Pharmaceutical had 5:1 split on the 29th of March 2016. Ono Pharmaceutical Co is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Ono Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ono Pharmaceutical has an asset utilization ratio of 48.89 percent. This implies that the Company is making $0.49 for each dollar of assets. An increasing asset utilization means that Ono Pharmaceutical Co is more efficient with each dollar of assets it utilizes for everyday operations.Ono Pharmaceutical Ownership Allocation
Ono Pharmaceutical owns a total of 488.31 Million outstanding shares. 30% of Ono Pharmaceutical Co outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Ono Pharmaceutical Profitability Analysis
The company reported the revenue of 361.36 B. Net Income was 80.52 B with profit before overhead, payroll, taxes, and interest of 267.85 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ono Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ono Pharmaceutical and how it compares across the competition.
About Ono Pharmaceutical Valuation
The pink sheet valuation mechanism determines Ono Pharmaceutical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Ono Pharmaceutical. We calculate exposure to Ono Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ono Pharmaceutical's related companies.Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. The company was founded in 1717 and is headquartered in Osaka, Japan. Ono Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 3687 people.
8 Steps to conduct Ono Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ono Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ono Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ono Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ono Pharmaceutical's revenue streams: Identify Ono Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ono Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ono Pharmaceutical's growth potential: Evaluate Ono Pharmaceutical's management, business model, and growth potential.
- Determine Ono Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ono Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Ono Pharmaceutical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Ono Pharmaceutical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 499.2 M | |
| Quarterly Earnings Growth Y O Y | 0.853 | |
| Forward Price Earnings | 11.5473 | |
| Retained Earnings | 644.8 B |
Complementary Tools for Ono Pink Sheet analysis
When running Ono Pharmaceutical's price analysis, check to measure Ono Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ono Pharmaceutical is operating at the current time. Most of Ono Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Ono Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ono Pharmaceutical's price. Additionally, you may evaluate how the addition of Ono Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |